Canada still testing J&J vaccine from US production facility

Toronto, May 14 (Sputnik)s Canadian health official are still probing the shipment of vaccine doses produced by Johnson & Johnson subsidiary Janssen Pharmaceuticals amid a US investigation into quality control issues at a vaccine manufacturing plant in the US state of Maryland, Deputy Chief Public Health Officer Dr. Howard Njoo said.
Last month, Johnson & Johnson admitted to having produced a faulty batch of coronavirus vaccines at an East Baltimore facility, reportedly due to a mix-up of two ingredients that led to the ruining of about 15 million doses.
Canada received its first shipment of 300,000 Johnson & Johnson vaccine doses – manufactured at the same East Baltimore Emergent BioSolutions facility currently under investigation – at the end of April.
“At this point it’s still a question of waiting for Health Canada determining that the doses are good or not good to go,” Njoo said on Thursday in response to a question about the 300,000 Johnson & Johnson vaccine doses.